Remicade Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Efficacy and Safety of Infliximab Biosimilar in Treatment of Resistant Hidradenitis Suppurativa
Condition:   Hidradenitis Suppurativa Intervention:   Biological: Infliximab biosimilar Sponsor:   Services Institute of Medical Sciences, Pakistan Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2022 Category: Research Source Type: clinical trials